Cencora | COR - Gewinn Vor Steuern

Aktienkurs
255.64
Täglich Wechseln
-5.29 -2.03%
Monatlich
-20.09%
Jährlich
-8.42%
Q2 Prognose
255.68




Gewinn Vor Steuern Veränderung Datum
Ambu A/S DKK 157M 4M 2026-03
Amplifon EUR 26.34M 19.18M 2025-12
Apollo Hospitals Enterprise Ltd INR 6.86B 179M 2025-12
Avanos Medical USD 1.2M 2.4M 2025-12
Brookdale Senior Living USD -41.15M 73.42M 2025-12
Cencora USD 955.61M 59.33M 2025-09
Coloplast 1.79B 236M 2025-12
Convatec Group USD 52M 6.3M 2024-06
Diasorin EUR 50.55M 11.9M 2025-09
Encompass Health USD 257.7M 37.8M 2025-12
Enovis USD -509.55M 57.32M 2025-12
GE HealthCare Technologies USD 643M 30M 2025-09
Hoya 77.57B 33.23B 2026-03
Med Life RON 11.88M 28.54M 2025-09
Oriola-kd EUR 2.2M 7.8M 2025-09
Pediatrix Medical Group USD -101.98M 162.6M 2025-09
Rede D'or Sao Luiz BRL 1.42B 74.95M 2026-03
Siemens Healthineers EUR 603M 133M 2025-12
Solventum Corp USD 332M 179M 2025-12
Sonova Holding CHF 234.3M 159.4M 2025-12
Supermax Corporation Bhd MYR -143.04M 41.22M 2025-09
Veradigm USD 35.3M 13.95M 2022-09
Zimmer Biomet Holdings USD 98M 320.7M 2025-12